ADU-S100
disodium;(1R,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(6-aminopurin-9-yl)-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol
Molecular Identity
ADU-S100
disodium;(1R,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(6-aminopurin-9-yl)-12-oxido-3-oxo-12-sulfanylidene-3-sulfido-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol
PubChem CID: 135390762
2D Structure
Properties
C20H22N10Na2O10P2S2
Molecular Formula
734.50
Molecular Weight
g/mol
734.0232
Exact Mass
Da
308
TPSA
May have limited oral absorption
4
H-Bond Donors
20
H-Bond Acceptors
1180
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
ADU-S1001638750-95-4MIW815Cdn agonist adu-S100FMW9ZVF53NML RR-S2 CDA Sodium SaltADU S100 [WHO-DD]MW-815Sting-activating cyclic dinucleotide agonist MIW815(2',3')-Rp,Rpc-diAMPS disodium1638750-95-4 (sodium)ADU-S100 disodiumUNII-FMW9ZVF53NML RR-S2 CDA disodiumNVP-MIW815
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to ADU-S100
Loading drug network...